The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant.

Standard

The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant. / Justenhoven, Christina; Obazee, Ofure; Winter, Stefan; Couch, Fergus J; Olson, Janet E; Hall, Per; Hannelius, Ulf; Li, Jingmei; Humphreys, Keith; Severi, Gianluca; Giles, Graham; Southey, Melissa; Baglietto, Laura; Fasching, Peter A; Beckmann, Matthias W; Ekici, Arif B; Hamann, Ute; Baisch, Christian; Harth, Volker; Rabstein, Sylvia; Lotz, Anne; Pesch, Beate; Brüning, Thomas; Ko, Yon-Dschun; Brauch, Hiltrud.

in: BREAST CANCER RES TR, Jahrgang 131, Nr. 1, 1, 2012, S. 347-350.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Justenhoven, C, Obazee, O, Winter, S, Couch, FJ, Olson, JE, Hall, P, Hannelius, U, Li, J, Humphreys, K, Severi, G, Giles, G, Southey, M, Baglietto, L, Fasching, PA, Beckmann, MW, Ekici, AB, Hamann, U, Baisch, C, Harth, V, Rabstein, S, Lotz, A, Pesch, B, Brüning, T, Ko, Y-D & Brauch, H 2012, 'The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant.', BREAST CANCER RES TR, Jg. 131, Nr. 1, 1, S. 347-350. <http://www.ncbi.nlm.nih.gov/pubmed/22037784?dopt=Citation>

APA

Justenhoven, C., Obazee, O., Winter, S., Couch, F. J., Olson, J. E., Hall, P., Hannelius, U., Li, J., Humphreys, K., Severi, G., Giles, G., Southey, M., Baglietto, L., Fasching, P. A., Beckmann, M. W., Ekici, A. B., Hamann, U., Baisch, C., Harth, V., ... Brauch, H. (2012). The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant. BREAST CANCER RES TR, 131(1), 347-350. [1]. http://www.ncbi.nlm.nih.gov/pubmed/22037784?dopt=Citation

Vancouver

Bibtex

@article{5b0f3ad1701347bca4fde68864a12f0b,
title = "The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant.",
keywords = "Humans, Female, Postmenopause, Risk, Breast Neoplasms/*genetics/pathology, Aryl Hydrocarbon Hydroxylases/*genetics, *Estrogen Replacement Therapy, Gonadal Steroid Hormones/*blood, Humans, Female, Postmenopause, Risk, Breast Neoplasms/*genetics/pathology, Aryl Hydrocarbon Hydroxylases/*genetics, *Estrogen Replacement Therapy, Gonadal Steroid Hormones/*blood",
author = "Christina Justenhoven and Ofure Obazee and Stefan Winter and Couch, {Fergus J} and Olson, {Janet E} and Per Hall and Ulf Hannelius and Jingmei Li and Keith Humphreys and Gianluca Severi and Graham Giles and Melissa Southey and Laura Baglietto and Fasching, {Peter A} and Beckmann, {Matthias W} and Ekici, {Arif B} and Ute Hamann and Christian Baisch and Volker Harth and Sylvia Rabstein and Anne Lotz and Beate Pesch and Thomas Br{\"u}ning and Yon-Dschun Ko and Hiltrud Brauch",
year = "2012",
language = "English",
volume = "131",
pages = "347--350",
journal = "BREAST CANCER RES TR",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

RIS

TY - JOUR

T1 - The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant.

AU - Justenhoven, Christina

AU - Obazee, Ofure

AU - Winter, Stefan

AU - Couch, Fergus J

AU - Olson, Janet E

AU - Hall, Per

AU - Hannelius, Ulf

AU - Li, Jingmei

AU - Humphreys, Keith

AU - Severi, Gianluca

AU - Giles, Graham

AU - Southey, Melissa

AU - Baglietto, Laura

AU - Fasching, Peter A

AU - Beckmann, Matthias W

AU - Ekici, Arif B

AU - Hamann, Ute

AU - Baisch, Christian

AU - Harth, Volker

AU - Rabstein, Sylvia

AU - Lotz, Anne

AU - Pesch, Beate

AU - Brüning, Thomas

AU - Ko, Yon-Dschun

AU - Brauch, Hiltrud

PY - 2012

Y1 - 2012

KW - Humans

KW - Female

KW - Postmenopause

KW - Risk

KW - Breast Neoplasms/genetics/pathology

KW - Aryl Hydrocarbon Hydroxylases/genetics

KW - Estrogen Replacement Therapy

KW - Gonadal Steroid Hormones/blood

KW - Humans

KW - Female

KW - Postmenopause

KW - Risk

KW - Breast Neoplasms/genetics/pathology

KW - Aryl Hydrocarbon Hydroxylases/genetics

KW - Estrogen Replacement Therapy

KW - Gonadal Steroid Hormones/blood

M3 - SCORING: Journal article

VL - 131

SP - 347

EP - 350

JO - BREAST CANCER RES TR

JF - BREAST CANCER RES TR

SN - 0167-6806

IS - 1

M1 - 1

ER -